- Home
- RLAY vs APPS Comparison
RLAY vs APPS Comparison
Compare RLAY & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- APPS
- Stock Information
- Founded
- RLAY 2015
- APPS 2007
- Country
- RLAY United States
- APPS United States
- Employees
- RLAY N/A
- APPS N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- APPS Multi-Sector Companies
- Sector
- RLAY Health Care
- APPS Miscellaneous
- Exchange
- RLAY Nasdaq
- APPS Nasdaq
- Market Cap
- RLAY 620.4M
- APPS 534.2M
- IPO Year
- RLAY 2020
- APPS N/A
- Fundamental
- Price
- RLAY $2.62
- APPS $2.72
- Analyst Decision
- RLAY Strong Buy
- APPS Hold
- Analyst Count
- RLAY 10
- APPS 4
- Target Price
- RLAY $19.33
- APPS $2.38
- AVG Volume (30 Days)
- RLAY 2.5M
- APPS 4.1M
- Earning Date
- RLAY 05-01-2025
- APPS 05-27-2025
- Dividend Yield
- RLAY N/A
- APPS N/A
- EPS Growth
- RLAY N/A
- APPS N/A
- EPS
- RLAY N/A
- APPS N/A
- Revenue
- RLAY $10,007,000.00
- APPS $483,577,000.00
- Revenue This Year
- RLAY N/A
- APPS N/A
- Revenue Next Year
- RLAY $544.28
- APPS $6.49
- P/E Ratio
- RLAY N/A
- APPS N/A
- Revenue Growth
- RLAY N/A
- APPS N/A
- 52 Week Low
- RLAY $2.45
- APPS $1.18
- 52 Week High
- RLAY $10.72
- APPS $6.86
- Technical
- Relative Strength Index (RSI)
- RLAY 32.07
- APPS 37.98
- Support Level
- RLAY $3.05
- APPS $3.24
- Resistance Level
- RLAY $3.08
- APPS $3.80
- Average True Range (ATR)
- RLAY 0.25
- APPS 0.30
- MACD
- RLAY -0.04
- APPS -0.07
- Stochastic Oscillator
- RLAY 11.64
- APPS 8.33
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.